Skip to main content
. 2014 Sep 9;3(11):1354–1362. doi: 10.5966/sctm.2014-0098

Figure 2.

Figure 2.

A two-stage microfluidic device with improved antibody density on the device surface enriched CD34+ stem cells in high purity. When antibody was rearranged and concentrated on the top surface of hydrogel inside the second-stage microfluidic device, the purity of collected CD34+ stem cells reached 82 ± 2% (mean ± SD). This purity level is significantly higher than our previous two-stage device design [22] (n = 4 per group, p < .01). Abbreviation: CD34+, CD34-positive.